nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—Nucleic Acid Synthesis Inhibitors—Capecitabine—prostate cancer	0.635	1	CiPCiCtD
Clofarabine—ABCG2—Cabazitaxel—prostate cancer	0.0381	0.212	CbGbCtD
Clofarabine—ABCG2—Estrone—prostate cancer	0.0372	0.207	CbGbCtD
Clofarabine—ABCG2—Conjugated Estrogens—prostate cancer	0.0243	0.136	CbGbCtD
Clofarabine—ABCG2—Mitoxantrone—prostate cancer	0.0221	0.123	CbGbCtD
Clofarabine—ABCG2—Estradiol—prostate cancer	0.0214	0.119	CbGbCtD
Clofarabine—ABCG2—Etoposide—prostate cancer	0.014	0.0778	CbGbCtD
Clofarabine—ABCG2—Docetaxel—prostate cancer	0.0128	0.0712	CbGbCtD
Clofarabine—ABCG2—Doxorubicin—prostate cancer	0.00952	0.0531	CbGbCtD
Clofarabine—POLA1—prostate gland—prostate cancer	0.00192	0.0724	CbGeAlD
Clofarabine—RRM2—prostate gland—prostate cancer	0.00183	0.0692	CbGeAlD
Clofarabine—POLA1—seminal vesicle—prostate cancer	0.00162	0.0613	CbGeAlD
Clofarabine—RRM1—prostate gland—prostate cancer	0.00152	0.0575	CbGeAlD
Clofarabine—RRM1—seminal vesicle—prostate cancer	0.00129	0.0486	CbGeAlD
Clofarabine—POLA1—urethra—prostate cancer	0.00128	0.0485	CbGeAlD
Clofarabine—RRM2—renal system—prostate cancer	0.00125	0.0472	CbGeAlD
Clofarabine—DCK—prostate gland—prostate cancer	0.00118	0.0447	CbGeAlD
Clofarabine—RRM1—renal system—prostate cancer	0.00104	0.0392	CbGeAlD
Clofarabine—RRM1—urethra—prostate cancer	0.00102	0.0385	CbGeAlD
Clofarabine—DCK—seminal vesicle—prostate cancer	0.001	0.0378	CbGeAlD
Clofarabine—POLA1—bone marrow—prostate cancer	0.000988	0.0373	CbGeAlD
Clofarabine—RRM2—bone marrow—prostate cancer	0.000944	0.0357	CbGeAlD
Clofarabine—POLA1—testis—prostate cancer	0.000845	0.0319	CbGeAlD
Clofarabine—RRM2—testis—prostate cancer	0.000807	0.0305	CbGeAlD
Clofarabine—DCK—urethra—prostate cancer	0.000792	0.0299	CbGeAlD
Clofarabine—RRM1—bone marrow—prostate cancer	0.000784	0.0296	CbGeAlD
Clofarabine—RRM1—testis—prostate cancer	0.000671	0.0253	CbGeAlD
Clofarabine—S-Adenosylmethionine—GNMT—prostate cancer	0.000667	0.287	CrCbGaD
Clofarabine—ABCG2—prostate gland—prostate cancer	0.00066	0.0249	CbGeAlD
Clofarabine—POLA1—lymph node—prostate cancer	0.000612	0.0231	CbGeAlD
Clofarabine—DCK—bone marrow—prostate cancer	0.000609	0.023	CbGeAlD
Clofarabine—RRM2—lymph node—prostate cancer	0.000585	0.0221	CbGeAlD
Clofarabine—ABCG2—seminal vesicle—prostate cancer	0.000558	0.0211	CbGeAlD
Clofarabine—DCK—testis—prostate cancer	0.000521	0.0197	CbGeAlD
Clofarabine—RRM1—Fulvestrant—Estradiol—prostate cancer	0.000505	0.24	CbGdCrCtD
Clofarabine—RRM1—lymph node—prostate cancer	0.000486	0.0184	CbGeAlD
Clofarabine—ABCG2—urethra—prostate cancer	0.000442	0.0167	CbGeAlD
Clofarabine—Azacitidine—DNMT1—prostate cancer	0.000424	0.182	CrCbGaD
Clofarabine—Decitabine—DNMT1—prostate cancer	0.000414	0.178	CrCbGaD
Clofarabine—DCK—lymph node—prostate cancer	0.000378	0.0143	CbGeAlD
Clofarabine—ABCG2—bone marrow—prostate cancer	0.00034	0.0128	CbGeAlD
Clofarabine—ABCG2—testis—prostate cancer	0.000291	0.011	CbGeAlD
Clofarabine—DCK—Estradiol valerate/Dienogest—Estrone—prostate cancer	0.000223	0.106	CbGdCrCtD
Clofarabine—ABCG2—lymph node—prostate cancer	0.000211	0.00796	CbGeAlD
Clofarabine—DCK—Fulvestrant—Estradiol—prostate cancer	0.00018	0.0854	CbGdCrCtD
Clofarabine—POLA1—Norethindrone—Ethinyl Estradiol—prostate cancer	0.000172	0.0815	CbGdCrCtD
Clofarabine—S-Adenosylmethionine—COMT—prostate cancer	0.000171	0.0736	CrCbGaD
Clofarabine—DCK—Estradiol valerate/Dienogest—Estradiol—prostate cancer	0.000169	0.08	CbGdCrCtD
Clofarabine—Adenosine monophosphate—PDE4D—prostate cancer	0.000167	0.0717	CrCbGaD
Clofarabine—DCK—Estradiol valerate/Dienogest—Ethinyl Estradiol—prostate cancer	0.000165	0.0781	CbGdCrCtD
Clofarabine—DCK—Levorphanol—Estrone—prostate cancer	0.000157	0.0745	CbGdCrCtD
Clofarabine—Adenosine monophosphate—SRC—prostate cancer	0.000146	0.0626	CrCbGaD
Clofarabine—POLA1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000137	0.0648	CbGdCrCtD
Clofarabine—DCK—Levorphanol—Estradiol—prostate cancer	0.000119	0.0564	CbGdCrCtD
Clofarabine—Cytarabine—SLC22A1—prostate cancer	0.000113	0.0488	CrCbGaD
Clofarabine—Cladribine—SLC22A1—prostate cancer	0.000104	0.0449	CrCbGaD
Clofarabine—DCK—Doxorubicin—Epirubicin—prostate cancer	8.27e-05	0.0392	CbGdCrCtD
Clofarabine—S-Adenosylmethionine—CYP2E1—prostate cancer	7.97e-05	0.0343	CrCbGaD
Clofarabine—DCK—Epirubicin—Doxorubicin—prostate cancer	7.65e-05	0.0363	CbGdCrCtD
Clofarabine—DCK—Levonorgestrel—Ethinyl Estradiol—prostate cancer	5.64e-05	0.0267	CbGdCrCtD
Clofarabine—Cytarabine—CYP3A4—prostate cancer	3.96e-05	0.017	CrCbGaD
Clofarabine—DCK—Desoximetasone—Prednisone—prostate cancer	3.39e-05	0.0161	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Prednisone—prostate cancer	3.29e-05	0.0156	CbGdCrCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	2.69e-05	0.000256	CcSEcCtD
Clofarabine—Hepatobiliary disease—Epirubicin—prostate cancer	2.68e-05	0.000256	CcSEcCtD
Clofarabine—Oedema—Docetaxel—prostate cancer	2.68e-05	0.000255	CcSEcCtD
Clofarabine—Epistaxis—Epirubicin—prostate cancer	2.68e-05	0.000255	CcSEcCtD
Clofarabine—Infection—Docetaxel—prostate cancer	2.67e-05	0.000254	CcSEcCtD
Clofarabine—Weight decreased—Doxorubicin—prostate cancer	2.66e-05	0.000254	CcSEcCtD
Clofarabine—Sinusitis—Epirubicin—prostate cancer	2.66e-05	0.000253	CcSEcCtD
Clofarabine—Feeling abnormal—Etoposide—prostate cancer	2.66e-05	0.000253	CcSEcCtD
Clofarabine—Diarrhoea—Mitoxantrone—prostate cancer	2.66e-05	0.000253	CcSEcCtD
Clofarabine—Vomiting—Estradiol—prostate cancer	2.65e-05	0.000252	CcSEcCtD
Clofarabine—Pneumonia—Doxorubicin—prostate cancer	2.64e-05	0.000251	CcSEcCtD
Clofarabine—Gastrointestinal pain—Etoposide—prostate cancer	2.64e-05	0.000251	CcSEcCtD
Clofarabine—Nervous system disorder—Docetaxel—prostate cancer	2.63e-05	0.000251	CcSEcCtD
Clofarabine—Thrombocytopenia—Docetaxel—prostate cancer	2.63e-05	0.00025	CcSEcCtD
Clofarabine—Rash—Estradiol—prostate cancer	2.63e-05	0.00025	CcSEcCtD
Clofarabine—Infestation NOS—Doxorubicin—prostate cancer	2.62e-05	0.00025	CcSEcCtD
Clofarabine—Infestation—Doxorubicin—prostate cancer	2.62e-05	0.00025	CcSEcCtD
Clofarabine—Dermatitis—Estradiol—prostate cancer	2.62e-05	0.00025	CcSEcCtD
Clofarabine—Anaemia—Prednisone—prostate cancer	2.62e-05	0.00025	CcSEcCtD
Clofarabine—Tachycardia—Docetaxel—prostate cancer	2.62e-05	0.000249	CcSEcCtD
Clofarabine—Headache—Estradiol—prostate cancer	2.61e-05	0.000248	CcSEcCtD
Clofarabine—Skin disorder—Docetaxel—prostate cancer	2.61e-05	0.000248	CcSEcCtD
Clofarabine—Agitation—Prednisone—prostate cancer	2.6e-05	0.000248	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	2.6e-05	0.000248	CcSEcCtD
Clofarabine—Oedema—Capecitabine—prostate cancer	2.6e-05	0.000247	CcSEcCtD
Clofarabine—Renal failure—Doxorubicin—prostate cancer	2.58e-05	0.000246	CcSEcCtD
Clofarabine—Infection—Capecitabine—prostate cancer	2.58e-05	0.000246	CcSEcCtD
Clofarabine—Neuropathy peripheral—Doxorubicin—prostate cancer	2.57e-05	0.000245	CcSEcCtD
Clofarabine—Haemoglobin—Epirubicin—prostate cancer	2.56e-05	0.000244	CcSEcCtD
Clofarabine—Stomatitis—Doxorubicin—prostate cancer	2.56e-05	0.000244	CcSEcCtD
Clofarabine—Jaundice—Doxorubicin—prostate cancer	2.56e-05	0.000244	CcSEcCtD
Clofarabine—Anorexia—Docetaxel—prostate cancer	2.56e-05	0.000244	CcSEcCtD
Clofarabine—Abdominal pain—Etoposide—prostate cancer	2.55e-05	0.000243	CcSEcCtD
Clofarabine—Body temperature increased—Etoposide—prostate cancer	2.55e-05	0.000243	CcSEcCtD
Clofarabine—Nervous system disorder—Capecitabine—prostate cancer	2.55e-05	0.000243	CcSEcCtD
Clofarabine—Haemorrhage—Epirubicin—prostate cancer	2.55e-05	0.000243	CcSEcCtD
Clofarabine—Thrombocytopenia—Capecitabine—prostate cancer	2.54e-05	0.000242	CcSEcCtD
Clofarabine—Tachycardia—Capecitabine—prostate cancer	2.53e-05	0.000241	CcSEcCtD
Clofarabine—Skin disorder—Capecitabine—prostate cancer	2.52e-05	0.00024	CcSEcCtD
Clofarabine—Urinary tract disorder—Epirubicin—prostate cancer	2.52e-05	0.00024	CcSEcCtD
Clofarabine—Hyperhidrosis—Capecitabine—prostate cancer	2.51e-05	0.000239	CcSEcCtD
Clofarabine—Oedema peripheral—Epirubicin—prostate cancer	2.51e-05	0.000239	CcSEcCtD
Clofarabine—Hypotension—Docetaxel—prostate cancer	2.51e-05	0.000239	CcSEcCtD
Clofarabine—Haematuria—Doxorubicin—prostate cancer	2.5e-05	0.000238	CcSEcCtD
Clofarabine—Connective tissue disorder—Epirubicin—prostate cancer	2.5e-05	0.000238	CcSEcCtD
Clofarabine—Urethral disorder—Epirubicin—prostate cancer	2.5e-05	0.000238	CcSEcCtD
Clofarabine—Hepatobiliary disease—Doxorubicin—prostate cancer	2.48e-05	0.000236	CcSEcCtD
Clofarabine—Epistaxis—Doxorubicin—prostate cancer	2.48e-05	0.000236	CcSEcCtD
Clofarabine—Anorexia—Capecitabine—prostate cancer	2.48e-05	0.000236	CcSEcCtD
Clofarabine—Nausea—Estradiol—prostate cancer	2.47e-05	0.000236	CcSEcCtD
Clofarabine—Vomiting—Mitoxantrone—prostate cancer	2.47e-05	0.000235	CcSEcCtD
Clofarabine—Sinusitis—Doxorubicin—prostate cancer	2.46e-05	0.000235	CcSEcCtD
Clofarabine—Hypertension—Prednisone—prostate cancer	2.45e-05	0.000233	CcSEcCtD
Clofarabine—Rash—Mitoxantrone—prostate cancer	2.45e-05	0.000233	CcSEcCtD
Clofarabine—Dermatitis—Mitoxantrone—prostate cancer	2.44e-05	0.000233	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.44e-05	0.000233	CcSEcCtD
Clofarabine—Headache—Mitoxantrone—prostate cancer	2.43e-05	0.000232	CcSEcCtD
Clofarabine—Hypotension—Capecitabine—prostate cancer	2.43e-05	0.000231	CcSEcCtD
Clofarabine—Arthralgia—Prednisone—prostate cancer	2.41e-05	0.00023	CcSEcCtD
Clofarabine—Myalgia—Prednisone—prostate cancer	2.41e-05	0.00023	CcSEcCtD
Clofarabine—Paraesthesia—Docetaxel—prostate cancer	2.41e-05	0.000229	CcSEcCtD
Clofarabine—Erythema multiforme—Epirubicin—prostate cancer	2.41e-05	0.000229	CcSEcCtD
Clofarabine—Anxiety—Prednisone—prostate cancer	2.4e-05	0.000229	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.4e-05	0.000228	CcSEcCtD
Clofarabine—Dyspnoea—Docetaxel—prostate cancer	2.39e-05	0.000228	CcSEcCtD
Clofarabine—Somnolence—Docetaxel—prostate cancer	2.38e-05	0.000227	CcSEcCtD
Clofarabine—Hypersensitivity—Etoposide—prostate cancer	2.38e-05	0.000226	CcSEcCtD
Clofarabine—Haemoglobin—Doxorubicin—prostate cancer	2.37e-05	0.000226	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.37e-05	0.000225	CcSEcCtD
Clofarabine—Cardiac disorder—Epirubicin—prostate cancer	2.36e-05	0.000225	CcSEcCtD
Clofarabine—Flushing—Epirubicin—prostate cancer	2.36e-05	0.000225	CcSEcCtD
Clofarabine—Haemorrhage—Doxorubicin—prostate cancer	2.36e-05	0.000224	CcSEcCtD
Clofarabine—Paraesthesia—Capecitabine—prostate cancer	2.33e-05	0.000222	CcSEcCtD
Clofarabine—Decreased appetite—Docetaxel—prostate cancer	2.33e-05	0.000222	CcSEcCtD
Clofarabine—Urinary tract disorder—Doxorubicin—prostate cancer	2.33e-05	0.000222	CcSEcCtD
Clofarabine—Oedema peripheral—Doxorubicin—prostate cancer	2.32e-05	0.000221	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Docetaxel—prostate cancer	2.32e-05	0.000221	CcSEcCtD
Clofarabine—Asthenia—Etoposide—prostate cancer	2.32e-05	0.000221	CcSEcCtD
Clofarabine—Connective tissue disorder—Doxorubicin—prostate cancer	2.32e-05	0.000221	CcSEcCtD
Clofarabine—Dyspnoea—Capecitabine—prostate cancer	2.32e-05	0.000221	CcSEcCtD
Clofarabine—Oedema—Prednisone—prostate cancer	2.31e-05	0.00022	CcSEcCtD
Clofarabine—Fatigue—Docetaxel—prostate cancer	2.31e-05	0.00022	CcSEcCtD
Clofarabine—Angiopathy—Epirubicin—prostate cancer	2.31e-05	0.00022	CcSEcCtD
Clofarabine—Urethral disorder—Doxorubicin—prostate cancer	2.31e-05	0.00022	CcSEcCtD
Clofarabine—Nausea—Mitoxantrone—prostate cancer	2.31e-05	0.00022	CcSEcCtD
Clofarabine—Immune system disorder—Epirubicin—prostate cancer	2.3e-05	0.000219	CcSEcCtD
Clofarabine—Infection—Prednisone—prostate cancer	2.3e-05	0.000219	CcSEcCtD
Clofarabine—Mediastinal disorder—Epirubicin—prostate cancer	2.3e-05	0.000219	CcSEcCtD
Clofarabine—Pain—Docetaxel—prostate cancer	2.29e-05	0.000218	CcSEcCtD
Clofarabine—Chills—Epirubicin—prostate cancer	2.29e-05	0.000218	CcSEcCtD
Clofarabine—Pruritus—Etoposide—prostate cancer	2.28e-05	0.000218	CcSEcCtD
Clofarabine—Nervous system disorder—Prednisone—prostate cancer	2.27e-05	0.000216	CcSEcCtD
Clofarabine—Tachycardia—Prednisone—prostate cancer	2.26e-05	0.000215	CcSEcCtD
Clofarabine—Decreased appetite—Capecitabine—prostate cancer	2.26e-05	0.000215	CcSEcCtD
Clofarabine—Alopecia—Epirubicin—prostate cancer	2.25e-05	0.000214	CcSEcCtD
Clofarabine—Skin disorder—Prednisone—prostate cancer	2.25e-05	0.000214	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Capecitabine—prostate cancer	2.24e-05	0.000214	CcSEcCtD
Clofarabine—Fatigue—Capecitabine—prostate cancer	2.24e-05	0.000213	CcSEcCtD
Clofarabine—Hyperhidrosis—Prednisone—prostate cancer	2.24e-05	0.000213	CcSEcCtD
Clofarabine—Mental disorder—Epirubicin—prostate cancer	2.23e-05	0.000213	CcSEcCtD
Clofarabine—Erythema multiforme—Doxorubicin—prostate cancer	2.23e-05	0.000212	CcSEcCtD
Clofarabine—Pain—Capecitabine—prostate cancer	2.22e-05	0.000212	CcSEcCtD
Clofarabine—Erythema—Epirubicin—prostate cancer	2.22e-05	0.000211	CcSEcCtD
Clofarabine—Malnutrition—Epirubicin—prostate cancer	2.22e-05	0.000211	CcSEcCtD
Clofarabine—Feeling abnormal—Docetaxel—prostate cancer	2.21e-05	0.000211	CcSEcCtD
Clofarabine—Diarrhoea—Etoposide—prostate cancer	2.21e-05	0.00021	CcSEcCtD
Clofarabine—Anorexia—Prednisone—prostate cancer	2.21e-05	0.00021	CcSEcCtD
Clofarabine—Gastrointestinal pain—Docetaxel—prostate cancer	2.19e-05	0.000209	CcSEcCtD
Clofarabine—Cardiac disorder—Doxorubicin—prostate cancer	2.19e-05	0.000208	CcSEcCtD
Clofarabine—Flushing—Doxorubicin—prostate cancer	2.19e-05	0.000208	CcSEcCtD
Clofarabine—Back pain—Epirubicin—prostate cancer	2.14e-05	0.000204	CcSEcCtD
Clofarabine—Feeling abnormal—Capecitabine—prostate cancer	2.14e-05	0.000204	CcSEcCtD
Clofarabine—Angiopathy—Doxorubicin—prostate cancer	2.14e-05	0.000204	CcSEcCtD
Clofarabine—Dizziness—Etoposide—prostate cancer	2.13e-05	0.000203	CcSEcCtD
Clofarabine—Immune system disorder—Doxorubicin—prostate cancer	2.13e-05	0.000203	CcSEcCtD
Clofarabine—Gastrointestinal pain—Capecitabine—prostate cancer	2.12e-05	0.000202	CcSEcCtD
Clofarabine—Mediastinal disorder—Doxorubicin—prostate cancer	2.12e-05	0.000202	CcSEcCtD
Clofarabine—Body temperature increased—Docetaxel—prostate cancer	2.12e-05	0.000202	CcSEcCtD
Clofarabine—Abdominal pain—Docetaxel—prostate cancer	2.12e-05	0.000202	CcSEcCtD
Clofarabine—Chills—Doxorubicin—prostate cancer	2.11e-05	0.000201	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Prednisone—prostate cancer	2.11e-05	0.000201	CcSEcCtD
Clofarabine—Alopecia—Doxorubicin—prostate cancer	2.08e-05	0.000198	CcSEcCtD
Clofarabine—Paraesthesia—Prednisone—prostate cancer	2.08e-05	0.000198	CcSEcCtD
Clofarabine—Mental disorder—Doxorubicin—prostate cancer	2.06e-05	0.000197	CcSEcCtD
Clofarabine—Abdominal pain—Capecitabine—prostate cancer	2.05e-05	0.000196	CcSEcCtD
Clofarabine—Body temperature increased—Capecitabine—prostate cancer	2.05e-05	0.000196	CcSEcCtD
Clofarabine—Vomiting—Etoposide—prostate cancer	2.05e-05	0.000195	CcSEcCtD
Clofarabine—Malnutrition—Doxorubicin—prostate cancer	2.05e-05	0.000195	CcSEcCtD
Clofarabine—Erythema—Doxorubicin—prostate cancer	2.05e-05	0.000195	CcSEcCtD
Clofarabine—Anaemia—Epirubicin—prostate cancer	2.05e-05	0.000195	CcSEcCtD
Clofarabine—Agitation—Epirubicin—prostate cancer	2.04e-05	0.000194	CcSEcCtD
Clofarabine—Rash—Etoposide—prostate cancer	2.04e-05	0.000194	CcSEcCtD
Clofarabine—Dermatitis—Etoposide—prostate cancer	2.03e-05	0.000194	CcSEcCtD
Clofarabine—Headache—Etoposide—prostate cancer	2.02e-05	0.000193	CcSEcCtD
Clofarabine—Decreased appetite—Prednisone—prostate cancer	2.01e-05	0.000192	CcSEcCtD
Clofarabine—Fatigue—Prednisone—prostate cancer	1.99e-05	0.00019	CcSEcCtD
Clofarabine—Leukopenia—Epirubicin—prostate cancer	1.98e-05	0.000189	CcSEcCtD
Clofarabine—Back pain—Doxorubicin—prostate cancer	1.98e-05	0.000189	CcSEcCtD
Clofarabine—Hypersensitivity—Docetaxel—prostate cancer	1.98e-05	0.000188	CcSEcCtD
Clofarabine—Cough—Epirubicin—prostate cancer	1.93e-05	0.000184	CcSEcCtD
Clofarabine—Asthenia—Docetaxel—prostate cancer	1.92e-05	0.000183	CcSEcCtD
Clofarabine—Nausea—Etoposide—prostate cancer	1.92e-05	0.000183	CcSEcCtD
Clofarabine—Hypertension—Epirubicin—prostate cancer	1.91e-05	0.000182	CcSEcCtD
Clofarabine—Hypersensitivity—Capecitabine—prostate cancer	1.91e-05	0.000182	CcSEcCtD
Clofarabine—Feeling abnormal—Prednisone—prostate cancer	1.91e-05	0.000182	CcSEcCtD
Clofarabine—Pruritus—Docetaxel—prostate cancer	1.9e-05	0.000181	CcSEcCtD
Clofarabine—Anaemia—Doxorubicin—prostate cancer	1.9e-05	0.000181	CcSEcCtD
Clofarabine—Gastrointestinal pain—Prednisone—prostate cancer	1.89e-05	0.00018	CcSEcCtD
Clofarabine—Myalgia—Epirubicin—prostate cancer	1.89e-05	0.00018	CcSEcCtD
Clofarabine—Arthralgia—Epirubicin—prostate cancer	1.89e-05	0.00018	CcSEcCtD
Clofarabine—Agitation—Doxorubicin—prostate cancer	1.89e-05	0.00018	CcSEcCtD
Clofarabine—Anxiety—Epirubicin—prostate cancer	1.88e-05	0.000179	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.87e-05	0.000179	CcSEcCtD
Clofarabine—Asthenia—Capecitabine—prostate cancer	1.86e-05	0.000177	CcSEcCtD
Clofarabine—Pruritus—Capecitabine—prostate cancer	1.84e-05	0.000175	CcSEcCtD
Clofarabine—Leukopenia—Doxorubicin—prostate cancer	1.84e-05	0.000175	CcSEcCtD
Clofarabine—Diarrhoea—Docetaxel—prostate cancer	1.84e-05	0.000175	CcSEcCtD
Clofarabine—Abdominal pain—Prednisone—prostate cancer	1.83e-05	0.000174	CcSEcCtD
Clofarabine—Body temperature increased—Prednisone—prostate cancer	1.83e-05	0.000174	CcSEcCtD
Clofarabine—Oedema—Epirubicin—prostate cancer	1.81e-05	0.000172	CcSEcCtD
Clofarabine—Infection—Epirubicin—prostate cancer	1.8e-05	0.000171	CcSEcCtD
Clofarabine—Cough—Doxorubicin—prostate cancer	1.79e-05	0.00017	CcSEcCtD
Clofarabine—Diarrhoea—Capecitabine—prostate cancer	1.78e-05	0.000169	CcSEcCtD
Clofarabine—Nervous system disorder—Epirubicin—prostate cancer	1.77e-05	0.000169	CcSEcCtD
Clofarabine—Dizziness—Docetaxel—prostate cancer	1.77e-05	0.000169	CcSEcCtD
Clofarabine—Thrombocytopenia—Epirubicin—prostate cancer	1.77e-05	0.000169	CcSEcCtD
Clofarabine—Hypertension—Doxorubicin—prostate cancer	1.77e-05	0.000169	CcSEcCtD
Clofarabine—Tachycardia—Epirubicin—prostate cancer	1.77e-05	0.000168	CcSEcCtD
Clofarabine—DCK—Metabolism—NCOA3—prostate cancer	1.76e-05	0.000357	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NQO1—prostate cancer	1.76e-05	0.000357	CbGpPWpGaD
Clofarabine—Skin disorder—Epirubicin—prostate cancer	1.76e-05	0.000167	CcSEcCtD
Clofarabine—Hyperhidrosis—Epirubicin—prostate cancer	1.75e-05	0.000167	CcSEcCtD
Clofarabine—RRM2—Metabolism—GSTT1—prostate cancer	1.75e-05	0.000354	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ACHE—prostate cancer	1.75e-05	0.000354	CbGpPWpGaD
Clofarabine—Arthralgia—Doxorubicin—prostate cancer	1.75e-05	0.000166	CcSEcCtD
Clofarabine—Myalgia—Doxorubicin—prostate cancer	1.75e-05	0.000166	CcSEcCtD
Clofarabine—Anxiety—Doxorubicin—prostate cancer	1.74e-05	0.000166	CcSEcCtD
Clofarabine—RRM1—Metabolism—TH—prostate cancer	1.74e-05	0.000352	CbGpPWpGaD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.73e-05	0.000165	CcSEcCtD
Clofarabine—RRM2—Metabolism—CYP2A6—prostate cancer	1.73e-05	0.00035	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—UGT2B15—prostate cancer	1.73e-05	0.000349	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GRHPR—prostate cancer	1.73e-05	0.000349	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CKMT2—prostate cancer	1.73e-05	0.000349	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—UGT2B17—prostate cancer	1.73e-05	0.000349	CbGpPWpGaD
Clofarabine—Anorexia—Epirubicin—prostate cancer	1.72e-05	0.000164	CcSEcCtD
Clofarabine—RRM1—Metabolism—CYP3A4—prostate cancer	1.72e-05	0.000348	CbGpPWpGaD
Clofarabine—Dizziness—Capecitabine—prostate cancer	1.72e-05	0.000164	CcSEcCtD
Clofarabine—Vomiting—Docetaxel—prostate cancer	1.71e-05	0.000162	CcSEcCtD
Clofarabine—Hypersensitivity—Prednisone—prostate cancer	1.7e-05	0.000162	CcSEcCtD
Clofarabine—Rash—Docetaxel—prostate cancer	1.69e-05	0.000161	CcSEcCtD
Clofarabine—RRM1—Metabolism—CYP1B1—prostate cancer	1.69e-05	0.000342	CbGpPWpGaD
Clofarabine—Hypotension—Epirubicin—prostate cancer	1.69e-05	0.000161	CcSEcCtD
Clofarabine—Dermatitis—Docetaxel—prostate cancer	1.69e-05	0.000161	CcSEcCtD
Clofarabine—DCK—Metabolism—HPGDS—prostate cancer	1.68e-05	0.000341	CbGpPWpGaD
Clofarabine—Headache—Docetaxel—prostate cancer	1.68e-05	0.00016	CcSEcCtD
Clofarabine—RRM2—Metabolism—AKR1C3—prostate cancer	1.68e-05	0.00034	CbGpPWpGaD
Clofarabine—Oedema—Doxorubicin—prostate cancer	1.67e-05	0.000159	CcSEcCtD
Clofarabine—DCK—Metabolism—CYP2C19—prostate cancer	1.67e-05	0.000339	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	1.67e-05	0.000339	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PRKACB—prostate cancer	1.67e-05	0.000338	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	1.67e-05	0.000338	CbGpPWpGaD
Clofarabine—Infection—Doxorubicin—prostate cancer	1.66e-05	0.000158	CcSEcCtD
Clofarabine—Asthenia—Prednisone—prostate cancer	1.66e-05	0.000158	CcSEcCtD
Clofarabine—RRM2—Metabolism—CYP17A1—prostate cancer	1.65e-05	0.000335	CbGpPWpGaD
Clofarabine—Vomiting—Capecitabine—prostate cancer	1.65e-05	0.000157	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.65e-05	0.000157	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	1.65e-05	0.000333	CbGpPWpGaD
Clofarabine—Nervous system disorder—Doxorubicin—prostate cancer	1.64e-05	0.000156	CcSEcCtD
Clofarabine—Thrombocytopenia—Doxorubicin—prostate cancer	1.64e-05	0.000156	CcSEcCtD
Clofarabine—Rash—Capecitabine—prostate cancer	1.64e-05	0.000156	CcSEcCtD
Clofarabine—RRM1—Metabolism—GGT1—prostate cancer	1.64e-05	0.000332	CbGpPWpGaD
Clofarabine—Pruritus—Prednisone—prostate cancer	1.64e-05	0.000156	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	1.64e-05	0.000331	CbGpPWpGaD
Clofarabine—Dermatitis—Capecitabine—prostate cancer	1.64e-05	0.000156	CcSEcCtD
Clofarabine—Tachycardia—Doxorubicin—prostate cancer	1.63e-05	0.000156	CcSEcCtD
Clofarabine—DCK—Metabolism—ACHE—prostate cancer	1.63e-05	0.000331	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTT1—prostate cancer	1.63e-05	0.000331	CbGpPWpGaD
Clofarabine—Headache—Capecitabine—prostate cancer	1.63e-05	0.000155	CcSEcCtD
Clofarabine—Skin disorder—Doxorubicin—prostate cancer	1.63e-05	0.000155	CcSEcCtD
Clofarabine—Paraesthesia—Epirubicin—prostate cancer	1.62e-05	0.000155	CcSEcCtD
Clofarabine—ABCG2—Metabolism—RFK—prostate cancer	1.62e-05	0.000329	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PGAM2—prostate cancer	1.62e-05	0.000329	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NAGLU—prostate cancer	1.62e-05	0.000329	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTM3—prostate cancer	1.62e-05	0.000329	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—MBTPS1—prostate cancer	1.62e-05	0.000329	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SULT2B1—prostate cancer	1.62e-05	0.000329	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AOX1—prostate cancer	1.62e-05	0.000329	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Doxorubicin—prostate cancer	1.62e-05	0.000154	CcSEcCtD
Clofarabine—DCK—Metabolism—CYP2A6—prostate cancer	1.61e-05	0.000327	CbGpPWpGaD
Clofarabine—Dyspnoea—Epirubicin—prostate cancer	1.61e-05	0.000154	CcSEcCtD
Clofarabine—RRM1—Metabolism—NCOA1—prostate cancer	1.61e-05	0.000327	CbGpPWpGaD
Clofarabine—Somnolence—Epirubicin—prostate cancer	1.61e-05	0.000153	CcSEcCtD
Clofarabine—Anorexia—Doxorubicin—prostate cancer	1.6e-05	0.000152	CcSEcCtD
Clofarabine—Nausea—Docetaxel—prostate cancer	1.59e-05	0.000152	CcSEcCtD
Clofarabine—RRM1—Metabolism—CYP19A1—prostate cancer	1.59e-05	0.000322	CbGpPWpGaD
Clofarabine—Diarrhoea—Prednisone—prostate cancer	1.58e-05	0.000151	CcSEcCtD
Clofarabine—RRM2—Metabolism—NCOA2—prostate cancer	1.58e-05	0.000319	CbGpPWpGaD
Clofarabine—Decreased appetite—Epirubicin—prostate cancer	1.57e-05	0.00015	CcSEcCtD
Clofarabine—DCK—Metabolism—AKR1C3—prostate cancer	1.57e-05	0.000318	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—GNG5—prostate cancer	1.57e-05	0.000317	CbGpPWpGaD
Clofarabine—Hypotension—Doxorubicin—prostate cancer	1.56e-05	0.000149	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Epirubicin—prostate cancer	1.56e-05	0.000149	CcSEcCtD
Clofarabine—DCK—Metabolism—PRKACB—prostate cancer	1.56e-05	0.000316	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TERT—prostate cancer	1.56e-05	0.000316	CbGpPWpGaD
Clofarabine—Fatigue—Epirubicin—prostate cancer	1.56e-05	0.000149	CcSEcCtD
Clofarabine—Pain—Epirubicin—prostate cancer	1.55e-05	0.000147	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1B—prostate cancer	1.55e-05	0.000313	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP17A1—prostate cancer	1.55e-05	0.000313	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	1.55e-05	0.000313	CbGpPWpGaD
Clofarabine—Nausea—Capecitabine—prostate cancer	1.54e-05	0.000147	CcSEcCtD
Clofarabine—ABCG2—Metabolism—AMACR—prostate cancer	1.54e-05	0.000311	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SRD5A2—prostate cancer	1.54e-05	0.000311	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NAT1—prostate cancer	1.54e-05	0.000311	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP3A43—prostate cancer	1.54e-05	0.000311	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—DEGS1—prostate cancer	1.54e-05	0.000311	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—RXRA—prostate cancer	1.53e-05	0.000311	CbGpPWpGaD
Clofarabine—Dizziness—Prednisone—prostate cancer	1.53e-05	0.000146	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.53e-05	0.000145	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—MDM2—prostate cancer	1.52e-05	0.000307	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—SLC5A5—prostate cancer	1.5e-05	0.000304	CbGpPWpGaD
Clofarabine—Paraesthesia—Doxorubicin—prostate cancer	1.5e-05	0.000143	CcSEcCtD
Clofarabine—Dyspnoea—Doxorubicin—prostate cancer	1.49e-05	0.000142	CcSEcCtD
Clofarabine—Feeling abnormal—Epirubicin—prostate cancer	1.49e-05	0.000142	CcSEcCtD
Clofarabine—Somnolence—Doxorubicin—prostate cancer	1.49e-05	0.000142	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—AKT1—prostate cancer	1.48e-05	0.0003	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Epirubicin—prostate cancer	1.48e-05	0.000141	CcSEcCtD
Clofarabine—RRM1—Metabolism—COMT—prostate cancer	1.48e-05	0.000299	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCND1—prostate cancer	1.48e-05	0.000299	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NCOA2—prostate cancer	1.47e-05	0.000298	CbGpPWpGaD
Clofarabine—Vomiting—Prednisone—prostate cancer	1.47e-05	0.00014	CcSEcCtD
Clofarabine—RRM1—Metabolism—GSTP1—prostate cancer	1.47e-05	0.000298	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP2E1—prostate cancer	1.47e-05	0.000297	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HSD17B1—prostate cancer	1.47e-05	0.000297	CbGpPWpGaD
Clofarabine—Rash—Prednisone—prostate cancer	1.46e-05	0.000139	CcSEcCtD
Clofarabine—Dermatitis—Prednisone—prostate cancer	1.46e-05	0.000139	CcSEcCtD
Clofarabine—Decreased appetite—Doxorubicin—prostate cancer	1.46e-05	0.000139	CcSEcCtD
Clofarabine—RRM2—Metabolism—NQO1—prostate cancer	1.45e-05	0.000294	CbGpPWpGaD
Clofarabine—Headache—Prednisone—prostate cancer	1.45e-05	0.000138	CcSEcCtD
Clofarabine—RRM1—Metabolism—ITPR1—prostate cancer	1.45e-05	0.000293	CbGpPWpGaD
Clofarabine—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.45e-05	0.000138	CcSEcCtD
Clofarabine—Fatigue—Doxorubicin—prostate cancer	1.44e-05	0.000137	CcSEcCtD
Clofarabine—Pain—Doxorubicin—prostate cancer	1.43e-05	0.000136	CcSEcCtD
Clofarabine—RRM2—Metabolism—TH—prostate cancer	1.43e-05	0.00029	CbGpPWpGaD
Clofarabine—Abdominal pain—Epirubicin—prostate cancer	1.43e-05	0.000136	CcSEcCtD
Clofarabine—Body temperature increased—Epirubicin—prostate cancer	1.43e-05	0.000136	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1A—prostate cancer	1.43e-05	0.000289	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	1.42e-05	0.000288	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP3A4—prostate cancer	1.42e-05	0.000287	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SLC5A5—prostate cancer	1.41e-05	0.000285	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—ATM—prostate cancer	1.4e-05	0.000284	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP1B1—prostate cancer	1.39e-05	0.000282	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN1B—prostate cancer	1.38e-05	0.00028	CbGpPWpGaD
Clofarabine—Feeling abnormal—Doxorubicin—prostate cancer	1.38e-05	0.000131	CcSEcCtD
Clofarabine—Nausea—Prednisone—prostate cancer	1.37e-05	0.000131	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	1.37e-05	0.000278	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP2E1—prostate cancer	1.37e-05	0.000278	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Doxorubicin—prostate cancer	1.37e-05	0.00013	CcSEcCtD
Clofarabine—RRM1—Metabolism—TYMS—prostate cancer	1.37e-05	0.000277	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—EP300—prostate cancer	1.36e-05	0.000275	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NQO1—prostate cancer	1.36e-05	0.000275	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GSTM1—prostate cancer	1.35e-05	0.000274	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GGT1—prostate cancer	1.35e-05	0.000273	CbGpPWpGaD
Clofarabine—DCK—Metabolism—TH—prostate cancer	1.34e-05	0.000271	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.33e-05	0.00027	CbGpPWpGaD
Clofarabine—Hypersensitivity—Epirubicin—prostate cancer	1.33e-05	0.000127	CcSEcCtD
Clofarabine—RRM2—Metabolism—NCOA1—prostate cancer	1.33e-05	0.000269	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—LPL—prostate cancer	1.33e-05	0.000269	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP3A4—prostate cancer	1.32e-05	0.000268	CbGpPWpGaD
Clofarabine—Body temperature increased—Doxorubicin—prostate cancer	1.32e-05	0.000126	CcSEcCtD
Clofarabine—Abdominal pain—Doxorubicin—prostate cancer	1.32e-05	0.000126	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CCND1—prostate cancer	1.32e-05	0.000267	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP19A1—prostate cancer	1.31e-05	0.000265	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—B4GALT4—prostate cancer	1.31e-05	0.000265	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HPGD—prostate cancer	1.31e-05	0.000265	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP1B1—prostate cancer	1.3e-05	0.000263	CbGpPWpGaD
Clofarabine—Asthenia—Epirubicin—prostate cancer	1.3e-05	0.000124	CcSEcCtD
Clofarabine—RRM1—Metabolism—CYP1A1—prostate cancer	1.28e-05	0.000259	CbGpPWpGaD
Clofarabine—Pruritus—Epirubicin—prostate cancer	1.28e-05	0.000122	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CDKN1A—prostate cancer	1.28e-05	0.000259	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ERCC2—prostate cancer	1.27e-05	0.000257	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—RXRA—prostate cancer	1.26e-05	0.000256	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GGT1—prostate cancer	1.26e-05	0.000255	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.26e-05	0.000255	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NCOA1—prostate cancer	1.24e-05	0.000251	CbGpPWpGaD
Clofarabine—Diarrhoea—Epirubicin—prostate cancer	1.24e-05	0.000118	CcSEcCtD
Clofarabine—Hypersensitivity—Doxorubicin—prostate cancer	1.23e-05	0.000117	CcSEcCtD
Clofarabine—ABCG2—Metabolism—TNFRSF21—prostate cancer	1.23e-05	0.000249	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP19A1—prostate cancer	1.22e-05	0.000248	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—COMT—prostate cancer	1.22e-05	0.000246	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—EP300—prostate cancer	1.21e-05	0.000246	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTP1—prostate cancer	1.21e-05	0.000245	CbGpPWpGaD
Clofarabine—Asthenia—Doxorubicin—prostate cancer	1.2e-05	0.000114	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.2e-05	0.000243	CbGpPWpGaD
Clofarabine—Dizziness—Epirubicin—prostate cancer	1.2e-05	0.000114	CcSEcCtD
Clofarabine—ABCG2—Metabolism—CYP7B1—prostate cancer	1.2e-05	0.000242	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—MTAP—prostate cancer	1.2e-05	0.000242	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—MTHFR—prostate cancer	1.19e-05	0.000242	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ITPR1—prostate cancer	1.19e-05	0.000241	CbGpPWpGaD
Clofarabine—Pruritus—Doxorubicin—prostate cancer	1.18e-05	0.000113	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—MYC—prostate cancer	1.18e-05	0.00024	CbGpPWpGaD
Clofarabine—DCK—Metabolism—RXRA—prostate cancer	1.18e-05	0.000239	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PPARA—prostate cancer	1.17e-05	0.000237	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SULT1E1—prostate cancer	1.17e-05	0.000236	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SRD5A1—prostate cancer	1.17e-05	0.000236	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	1.16e-05	0.000235	CbGpPWpGaD
Clofarabine—Vomiting—Epirubicin—prostate cancer	1.15e-05	0.00011	CcSEcCtD
Clofarabine—Diarrhoea—Doxorubicin—prostate cancer	1.15e-05	0.000109	CcSEcCtD
Clofarabine—Rash—Epirubicin—prostate cancer	1.14e-05	0.000109	CcSEcCtD
Clofarabine—Dermatitis—Epirubicin—prostate cancer	1.14e-05	0.000109	CcSEcCtD
Clofarabine—DCK—Metabolism—COMT—prostate cancer	1.14e-05	0.00023	CbGpPWpGaD
Clofarabine—Headache—Epirubicin—prostate cancer	1.13e-05	0.000108	CcSEcCtD
Clofarabine—DCK—Metabolism—GSTP1—prostate cancer	1.13e-05	0.000229	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—TYMS—prostate cancer	1.13e-05	0.000228	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ITPR1—prostate cancer	1.11e-05	0.000226	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTM1—prostate cancer	1.11e-05	0.000225	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ACSL4—prostate cancer	1.11e-05	0.000225	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HSD17B3—prostate cancer	1.11e-05	0.000225	CbGpPWpGaD
Clofarabine—Dizziness—Doxorubicin—prostate cancer	1.11e-05	0.000105	CcSEcCtD
Clofarabine—RRM1—Metabolism—CAV1—prostate cancer	1.1e-05	0.000223	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—LPL—prostate cancer	1.09e-05	0.000221	CbGpPWpGaD
Clofarabine—Nausea—Epirubicin—prostate cancer	1.07e-05	0.000102	CcSEcCtD
Clofarabine—ABCG2—Metabolism—ARG2—prostate cancer	1.07e-05	0.000216	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—UMPS—prostate cancer	1.07e-05	0.000216	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PHGDH—prostate cancer	1.07e-05	0.000216	CbGpPWpGaD
Clofarabine—Vomiting—Doxorubicin—prostate cancer	1.06e-05	0.000101	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.06e-05	0.000215	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MYC—prostate cancer	1.06e-05	0.000214	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—prostate cancer	1.06e-05	0.000214	CbGpPWpGaD
Clofarabine—Rash—Doxorubicin—prostate cancer	1.06e-05	0.000101	CcSEcCtD
Clofarabine—RRM2—Metabolism—CYP1A1—prostate cancer	1.06e-05	0.000214	CbGpPWpGaD
Clofarabine—Dermatitis—Doxorubicin—prostate cancer	1.05e-05	0.0001	CcSEcCtD
Clofarabine—DCK—Metabolism—TYMS—prostate cancer	1.05e-05	0.000213	CbGpPWpGaD
Clofarabine—Headache—Doxorubicin—prostate cancer	1.05e-05	9.99e-05	CcSEcCtD
Clofarabine—RRM2—Metabolism—ERCC2—prostate cancer	1.05e-05	0.000212	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—LDHB—prostate cancer	1.05e-05	0.000212	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTM1—prostate cancer	1.04e-05	0.000211	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MDM2—prostate cancer	1.04e-05	0.00021	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP3A5—prostate cancer	1.03e-05	0.000208	CbGpPWpGaD
Clofarabine—DCK—Metabolism—LPL—prostate cancer	1.02e-05	0.000207	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCND1—prostate cancer	1.01e-05	0.000204	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—RXRA—prostate cancer	1.01e-05	0.000204	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CG—prostate cancer	1e-05	0.000203	CbGpPWpGaD
Clofarabine—Nausea—Doxorubicin—prostate cancer	9.94e-06	9.47e-05	CcSEcCtD
Clofarabine—ABCG2—Metabolism—PDHA1—prostate cancer	9.91e-06	0.000201	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—TCN2—prostate cancer	9.91e-06	0.000201	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTA3—prostate cancer	9.91e-06	0.000201	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—UCP3—prostate cancer	9.91e-06	0.000201	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP1A1—prostate cancer	9.86e-06	0.0002	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—MTHFR—prostate cancer	9.84e-06	0.000199	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ERCC2—prostate cancer	9.78e-06	0.000198	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—prostate cancer	9.77e-06	0.000198	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PPARA—prostate cancer	9.65e-06	0.000195	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—INS—prostate cancer	9.5e-06	0.000192	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN1B—prostate cancer	9.46e-06	0.000192	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC22A3—prostate cancer	9.46e-06	0.000191	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HSD3B1—prostate cancer	9.46e-06	0.000191	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CREBBP—prostate cancer	9.31e-06	0.000188	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—EP300—prostate cancer	9.29e-06	0.000188	CbGpPWpGaD
Clofarabine—DCK—Metabolism—MTHFR—prostate cancer	9.19e-06	0.000186	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CAV1—prostate cancer	9.07e-06	0.000184	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—TBXAS1—prostate cancer	9.07e-06	0.000184	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTA4—prostate cancer	9.07e-06	0.000184	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCND1—prostate cancer	9.03e-06	0.000183	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PPARA—prostate cancer	9.02e-06	0.000183	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTA2—prostate cancer	8.84e-06	0.000179	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CD—prostate cancer	8.82e-06	0.000179	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN1A—prostate cancer	8.73e-06	0.000177	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SULT1A1—prostate cancer	8.73e-06	0.000177	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ABCG5—prostate cancer	8.73e-06	0.000177	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—prostate cancer	8.69e-06	0.000176	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTA1—prostate cancer	8.52e-06	0.000173	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CAV1—prostate cancer	8.48e-06	0.000172	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTO1—prostate cancer	8.43e-06	0.000171	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NAT2—prostate cancer	8.43e-06	0.000171	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HSD3B2—prostate cancer	8.43e-06	0.000171	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NOS3—prostate cancer	8.33e-06	0.000169	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—EP300—prostate cancer	8.31e-06	0.000168	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CG—prostate cancer	8.27e-06	0.000167	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MYC—prostate cancer	8.1e-06	0.000164	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—LRP2—prostate cancer	8.08e-06	0.000164	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PLCB2—prostate cancer	8.08e-06	0.000164	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP2C18—prostate cancer	8.08e-06	0.000164	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—P4HB—prostate cancer	7.92e-06	0.00016	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—INS—prostate cancer	7.82e-06	0.000158	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CG—prostate cancer	7.72e-06	0.000156	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC22A1—prostate cancer	7.71e-06	0.000156	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—PPARA—prostate cancer	7.71e-06	0.000156	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CB—prostate cancer	7.69e-06	0.000156	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CREBBP—prostate cancer	7.66e-06	0.000155	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTGS2—prostate cancer	7.62e-06	0.000154	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SULT2A1—prostate cancer	7.51e-06	0.000152	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—MED12—prostate cancer	7.39e-06	0.00015	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GNG5—prostate cancer	7.33e-06	0.000148	CbGpPWpGaD
Clofarabine—DCK—Metabolism—INS—prostate cancer	7.31e-06	0.000148	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CD—prostate cancer	7.27e-06	0.000147	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MYC—prostate cancer	7.24e-06	0.000147	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CREBBP—prostate cancer	7.16e-06	0.000145	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NCOA3—prostate cancer	7.06e-06	0.000143	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NOS3—prostate cancer	6.86e-06	0.000139	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CD—prostate cancer	6.79e-06	0.000137	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HPGDS—prostate cancer	6.74e-06	0.000136	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP2C19—prostate cancer	6.7e-06	0.000136	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTEN—prostate cancer	6.65e-06	0.000135	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTT1—prostate cancer	6.54e-06	0.000132	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ACHE—prostate cancer	6.54e-06	0.000132	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP2A6—prostate cancer	6.46e-06	0.000131	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NOS3—prostate cancer	6.41e-06	0.00013	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—EP300—prostate cancer	6.34e-06	0.000128	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CB—prostate cancer	6.33e-06	0.000128	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKR1C3—prostate cancer	6.28e-06	0.000127	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTGS2—prostate cancer	6.28e-06	0.000127	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PRKACB—prostate cancer	6.25e-06	0.000127	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP17A1—prostate cancer	6.19e-06	0.000125	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.12e-06	0.000124	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—prostate cancer	5.95e-06	0.00012	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CB—prostate cancer	5.92e-06	0.00012	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NCOA2—prostate cancer	5.89e-06	0.000119	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTGS2—prostate cancer	5.86e-06	0.000119	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC5A5—prostate cancer	5.62e-06	0.000114	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP2E1—prostate cancer	5.49e-06	0.000111	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTEN—prostate cancer	5.47e-06	0.000111	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NQO1—prostate cancer	5.43e-06	0.00011	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—TH—prostate cancer	5.35e-06	0.000108	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP3A4—prostate cancer	5.3e-06	0.000107	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—EP300—prostate cancer	5.22e-06	0.000106	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP1B1—prostate cancer	5.21e-06	0.000105	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTEN—prostate cancer	5.11e-06	0.000104	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GGT1—prostate cancer	5.04e-06	0.000102	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NCOA1—prostate cancer	4.97e-06	0.000101	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP19A1—prostate cancer	4.9e-06	9.91e-05	CbGpPWpGaD
Clofarabine—DCK—Metabolism—EP300—prostate cancer	4.88e-06	9.88e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—RXRA—prostate cancer	4.72e-06	9.57e-05	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CA—prostate cancer	4.69e-06	9.49e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—COMT—prostate cancer	4.55e-06	9.22e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTP1—prostate cancer	4.53e-06	9.17e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ITPR1—prostate cancer	4.46e-06	9.03e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—TYMS—prostate cancer	4.21e-06	8.53e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTM1—prostate cancer	4.16e-06	8.43e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—LPL—prostate cancer	4.09e-06	8.27e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP1A1—prostate cancer	3.95e-06	7.99e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ERCC2—prostate cancer	3.91e-06	7.92e-05	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CA—prostate cancer	3.86e-06	7.82e-05	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—AKT1—prostate cancer	3.83e-06	7.76e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—MTHFR—prostate cancer	3.68e-06	7.45e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PPARA—prostate cancer	3.61e-06	7.31e-05	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CA—prostate cancer	3.61e-06	7.31e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CAV1—prostate cancer	3.39e-06	6.87e-05	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKT1—prostate cancer	3.15e-06	6.39e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CG—prostate cancer	3.09e-06	6.26e-05	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKT1—prostate cancer	2.95e-06	5.97e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—INS—prostate cancer	2.93e-06	5.92e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CREBBP—prostate cancer	2.87e-06	5.8e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CD—prostate cancer	2.72e-06	5.5e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NOS3—prostate cancer	2.57e-06	5.2e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CB—prostate cancer	2.37e-06	4.8e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTGS2—prostate cancer	2.35e-06	4.75e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTEN—prostate cancer	2.05e-06	4.14e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—EP300—prostate cancer	1.95e-06	3.95e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CA—prostate cancer	1.44e-06	2.92e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKT1—prostate cancer	1.18e-06	2.39e-05	CbGpPWpGaD
